Myomo, Inc.

MYO ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016
Operating Activities
Net Income $-12.1M $-3.6M
Depreciation & Amortization — —
Depreciation $11.4K $7.7K
Amortization — —
Stock-Based Compensation $279.5K $94.1K
Net Cash from Operating Activities $-6.2M $-3.2M
Investing Activities
Capital Expenditures $67.0K $1.9K
Business Acquisitions — —
Net Cash from Investing Activities $-67.0K $-1.9K
Financing Activities
Dividends Paid — —
Stock Repurchases — —
Net Cash from Financing Activities $18.4M $3.0M
Net Change in Cash $12.2M $-245.4K
Free Cash Flow $-6.2M $-3.2M
← Newer Page 2 of 2 Older →